| Literature DB >> 35665560 |
Elizabeth K Mallott1,2,3, Lotte H Skovmand4, Paul A Garber5,6,7, Katherine R Amato1.
Abstract
Mammals rely on the metabolic functions of their gut microbiota to meet their energetic needs and digest potentially toxic components in their diet. The gut microbiome plastically responds to shifts in host diet and may buffer variation in energy and nutrient availability. However, it is unclear how seasonal differences in the gut microbiome influence microbial metabolism and nutrients available to hosts. In this study, we examine seasonal variation in the gut metabolome of black howler monkeys (Alouatta pigra) to determine whether those variations are associated with differences in gut microbiome composition and nutrient intake, and if plasticity in the gut microbiome buffers shortfalls in energy or nutrient intake. We integrated data on the metabolome of 81 faecal samples from 16 individuals collected across three distinct seasons with gut microbiome, nutrient intake and plant metabolite consumption data from the same period. Faecal metabolite profiles differed significantly between seasons and were strongly associated with changes in plant metabolite consumption. However, microbial community composition and faecal metabolite composition were not strongly associated. Additionally, the connectivity and stability of faecal metabolome networks varied seasonally, with network connectivity being highest during the dry, fruit-dominated season when black howler monkey diets were calorically and nutritionally constrained. Network stability was highest during the dry, leaf-dominated season when most nutrients were being consumed at intermediate rates. Our results suggest that the gut microbiome buffers seasonal variation in dietary intake, and that the buffering effect is most limited when host diet becomes calorically or nutritionally restricted.Entities:
Keywords: black howler monkey; diet-microbiome interactions; faecal metabolites; plant metabolites
Mesh:
Year: 2022 PMID: 35665560 PMCID: PMC9543302 DOI: 10.1111/mec.16559
Source DB: PubMed Journal: Mol Ecol ISSN: 0962-1083 Impact factor: 6.622
Energy and nutrient intake profiles for each of the three seasons experienced by the study population of black howler monkeys. Energy consumption is expressed as energy per metabolic body weight (MBW) and nutrient intake values are expressed as grams per metabolic body weight
| Season | Energy (kcal/MBW) | Protein (g/MBW) | Lipid (g/MBW) | Nonstructural carbohydrate (g/MBW) | Neutral detergent fibre (g/MBW) |
|---|---|---|---|---|---|
| Wet, Fruit‐Dominated (WFD) | High (177.4–182.9) | Intermediate to high (9.4–11.9) | High (3.2–4.2) | Intermediate to high (29.0–29.7) | High (42.3–50.3) |
| Dry, Leaf‐Dominated (DLD) | Intermediate (105.5–172.4) | Intermediate to high (7.7–10.0) | Low to intermediate (1.2–3.2) | Low (12.4–16.2) | Intermediate (27.2–39.9) |
| Dry, Fruit‐Dominated (DFD) | Low (106.6–114.5) | Low (4.7–5.3) | Low to intermediate (1.8–2.1) | Intermediate to high (16.3–17.0) | Low (21.9–24.7) |
FIGURE 1Plot of the first and second components from the PLS‐DA analysis. Red triangles denote data points from the DFD season, green pluses denote data points from the DLD season and blue crosses denote data points from the WFD season. Ellipses encircle 95% confidence intervals
Pathways that were differentially enriched between each pair of seasons and the associated holm‐corrected p‐value, and the ratio of detected metabolites in the pathway to total pathway metabolites
| Metabolic pathway | WFD vs. DLD | DLD vs. DFD | DFD vs. WFD | No. of metabolites detected |
|---|---|---|---|---|
| Alanine metabolism |
| .195 | 1.000 | 5/17 |
| Alpha linolenic acid and linoleic acid metabolism | 1.000 |
| .187 | 1/19 |
| Amino sugar metabolism |
|
| 1.000 | 4/33 |
| Ammonia recycling |
| .123 | 1.000 | 6/32 |
| Arachidonic acid metabolism |
|
| 1.000 | 1/69 |
| Arginine and proline metabolism |
|
|
| 8/53 |
| Aspartate metabolism |
| .151 |
| 4/35 |
| Beta oxidation of very long chain fatty acids | 1.000 | .480 | .933 | 5/17 |
| Beta‐alanine metabolism |
| .273 | 1.000 | 5/34 |
| Betaine metabolism | .059 | 1.000 | .216 | 1/21 |
| Bile acid biosynthesis |
| 1.000 |
| 4/65 |
| Biotin metabolism |
| 1.000 | 1.000 | 1/8 |
| Butyrate metabolism | 1.000 | .412 | 1.000 | 1/19 |
| Cardiolipin biosynthesis |
| 1.000 |
| 1/11 |
| Carnitine synthesis | .134 | .893 | 1.000 | 3/22 |
| Catecholamine biosynthesis | 1.000 | 1.000 | 1.000 | 1/20 |
| Citric acid cycle |
| 1.000 |
| 4/32 |
| Cysteine metabolism |
| .139 | 1.000 | 3/26 |
|
| 1.000 | 1.000 | .814 | 1/11 |
| De novo triacylglycerol biosynthesis |
| 1.000 |
| 1/9 |
| Fatty acid biosynthesis | .057 | 1.000 |
| 6/35 |
| Fatty acid elongation in mitochondria |
| 1.000 |
| 1/35 |
| Fatty acid metabolism |
| 1.000 |
| 1/43 |
| Folate metabolism |
|
| 1.000 | 1/29 |
| Fructose and mannose degradation |
| .363 | 1.000 | 3/32 |
| Galactose metabolism | 1.000 |
|
| 8/38 |
| Gluconeogenesis |
| 1.000 | 1.000 | 5/35 |
| Glucose–alanine cycle |
| .146 | 1.000 | 4/13 |
| Glutamate metabolism |
| .129 | 1.000 | 8/49 |
| Glutathione metabolism |
| .141 | 1.000 | 5/21 |
| Glycerol phosphate shuttle |
| 1.000 |
| 3/11 |
| Glycerolipid metabolism |
| .058 |
| 5/25 |
| Glycine and serine metabolism |
| .146 | .995 | 10/59 |
| Glycolysis |
| 1.000 | 1.000 | 3/25 |
| Histidine metabolism |
|
| 1.000 | 2/43 |
| Homocysteine degradation | 1.000 | .224 | 1.000 | 2/9 |
| Inositol metabolism |
| 1.000 |
| 3/33 |
| Inositol phosphate metabolism |
| 1.000 |
| 2/26 |
| Ketone body metabolism | 1.000 | .412 | 1.000 | 1/13 |
| Lactose degradation | 1.000 | 1.000 | 1.000 | 2/9 |
| Lactose synthesis |
| 1.000 | 1.000 | 2/20 |
| Lysine degradation |
|
| 1.000 | 3/30 |
| Malate–aspartate shuttle |
|
| 1.000 | 3/10 |
| Methionine metabolism | .127 | .347 | .821 | 6/43 |
| Mitochondrial beta‐oxidation of long chain saturated fatty acids | 1.000 | 1.000 | 1.000 | 1/28 |
| Mitochondrial beta‐oxidation of medium chain saturated fatty acids | 1.000 | 1.000 | 1.000 | 1/27 |
| Mitochondrial beta‐oxidation of short chain saturated fatty acids | 1.000 | 1.000 | 1.000 | 1/27 |
| Mitochondrial electron transport chain |
| 1.000 |
| 3/19 |
| Nicotinate and nicotinamide metabolism |
|
| 1.000 | 4/37 |
| Nucleotide sugar metabolism | 1.000 | 1.000 | 1.000 | 1/20 |
| Oxidation of branched chain fatty acids | 1.000 | .412 | 1.000 | 1/26 |
| Pantothenate and CoA biosynthesis | .267 | 1.000 | 1.000 | 1/21 |
| Pentose phosphate pathway |
| 1.000 | .624 | 1/29 |
| Phenylacetate metabolism | .752 | 1.000 | 1.000 | 1/9 |
| Phenylalanine and tyrosine metabolism |
| .180 |
| 4/28 |
| Phosphatidylcholine biosynthesis | 1.000 | .115 | 1.000 | 1/14 |
| Phosphatidylethanolamine biosynthesis | 1.000 |
| 1.000 | 2/12 |
| Phosphatidylinositol phosphate metabolism | .664 | 1.000 |
| 1/17 |
| Phospholipid biosynthesis |
| .444 |
| 2/29 |
| Phytanic acid peroxisomal oxidation | 1.000 | .412 | 1.000 | 1/26 |
| Plasmalogen synthesis |
| 1.000 |
| 3/26 |
| Porphyrin metabolism | 1.000 | 1.000 | 1.000 | 1/40 |
| Propanoate metabolism |
| .123 | 1.000 | 7/42 |
| Purine metabolism |
| .128 |
| 10/74 |
| Pyrimidine metabolism | .059 | 1.000 | .355 | 5/59 |
| Pyruvaldehyde degradation | .063 | 1.000 | 1.000 | 1/10 |
| Pyruvate metabolism |
| 1.000 | 1.000 | 3/48 |
| Riboflavin metabolism | 1.000 | 1.000 | .784 | 1/20 |
| Selenoamino acid metabolism |
| .153 | .207 | 5/28 |
| Spermidine and spermine biosynthesis | 1.000 | 1.000 | 1.000 | 1/18 |
| Sphingolipid metabolism | 1.000 | .151 | 1.000 | 3/40 |
| Starch and sucrose metabolism | 1.000 | .123 | .187 | 4/31 |
| Steroid biosynthesis |
| 1.000 |
| 4/48 |
| Steroidogenesis | 1.000 | 1.000 | 1.000 | 1/43 |
| Threonine and 2‐oxobutanoate degradation | 1.000 | 1.000 | 1.000 | 2/20 |
| Thyroid hormone synthesis | 1.000 | 1.000 | 1.000 | 1/13 |
| Transfer of acetyl groups into mitochondria | .315 | 1.000 | 1.000 | 3/22 |
| Trehalose degradation | 1.000 | 1.000 | 1.000 | 1/11 |
| Tryptophan metabolism |
| .141 | 1.000 | 3/60 |
| Tyrosine metabolism |
| .061 |
| 6/72 |
| Ubiquinone biosynthesis | 1.000 | 1.000 | 1.000 | 1/20 |
| Urea cycle |
| .163 |
| 7/29 |
| Valine, leucine and isoleucine degradation |
|
| 1.000 | 5/60 |
| Vitamin B6 metabolism |
| 1.000 | .784 | 1/20 |
| Warburg effect |
| .227 |
| 8/58 |
Notes: Cells highlighted in green are pathways with metabolites that are consistently higher in abundance in the first season listed, red cells are pathways with metabolites that are consistently lower in abundance in the first season listed and cells highlighted in yellow are pathways with no consistent direction of effect.
FIGURE 2Faecal microbial interaction network calculated from all data. Nodes that were significantly positively correlated after FDR correction (q < .05 and rho > .5) are shown. Node colour denotes mean shortest path length (lowest = yellow, highest = purple) and node border width increases with higher values of betweenness centrality. Edge colour indicates edge betweenness values (lowest = purple, highest = blue) and edge width increases with higher values of rho
Network attributes for metabolites present in >50% of samples within each season
| Season | Mean shortest path length | Mean edge betweenness | Mean betweenness centrality | Mean clustering coefficient | Network density | Number of clusters | Mean cluster size |
|---|---|---|---|---|---|---|---|
| WFD | 1.382 ± 0.493 | 9.103 ± 7.731 | 0.077 ± 0.235 | 0.168 ± 0.290 | 0.058 | 4 | 6.25 ± 7.361 |
| DLD | 1.950 ± 0.789 | 18.826 ± 19.185 | 0.116 ± 0.223 | 0.167 ± 0.260 | 0.118 | 6 | 4.667 ± 5.086 |
| DFD | 2.839 ± 1.145 | 62.015 ± 65.232 | 0.064 ± 0.128 | 0.284 ± 0.352 | 0.059 | 8 | 8.375 ± 15.702 |
FIGURE 3Faecal metabolite interaction networks calculated from all data (a), samples from the WFD season (b), DLD season (c) and DFD season (d). Nodes that were significantly positively correlated after FDR correction (q < .05 and rho > .5) are shown. Node colour denotes mean shortest path length (lowest = yellow, highest = purple) and node border width increases with higher values of betweenness centrality. Edge colour indicates edge betweenness values (lowest = red, highest = blue) and edge width increases with higher values of rho
FIGURE 4Faecal metabolite–microbe interaction network calculated from all data points. Nodes that were significantly positively correlated (p < .05 and rho > .5) are shown. Node colour denotes mean shortest path length (lowest = yellow, highest = purple) and node border width increases with higher values of betweenness centrality. Edge colour indicates edge betweenness values (lowest = red, highest = blue) and edge width increases with higher values of rho
FIGURE 5Plant metabolite‐faecal metabolite interaction network calculated from all data points across all seasons. Nodes that were significantly positively correlated (p < .05 and rho > .5) are shown. Node colour denotes mean shortest path length (lowest = yellow, highest = purple) and node border width increases with higher values of betweenness centrality. Edge colour indicates edge betweenness values (lowest = red, highest = blue) and edge width increases with higher values of rho. Direction of arrow is from source (plant metabolite) to target (faecal metabolite)